Followers | 546 |
Posts | 8175 |
Boards Moderated | 3 |
Alias Born | 10/23/2016 |
![](https://investorshub.advfn.com/uicon/580570.png?cb=1482357415)
Saturday, April 10, 2021 12:20:12 PM
But they are diff companies, im seeing alot here......could go higher......or lower.......but as James Dean used to say: ‘Any either other way’, three cents is dirt cheap with all the massive dd and new events here now and years of research and Patents.......where we are at now, will i think be looked at as extremely cheap this summer.
For me, until we hit a market cap of at least $500 mil, im none too worried, $500 mil MC which is standard fare for sooooo many biotech Naz stocks with nomproduct out and may never have one.....in pre-Phase or Phase I, havent made a dollar, have $20 mil in debt...yet their stocks trade over a dollar because of Potential. Biotech Potential......and with the huge licensing deal last week, the new Patent granted last month, and alll the other DD we are seeing......as some have been saying RGBP has more going for it then many Naz biotechs, right now.....and pps is below .03. i like the upside here, its rather staggering.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM